---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-016345"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T06:25:42.288120+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Zura Bio to present at Leerink Partners Global Healthcare Conference on March 11, 2025

## Summary
- Members of senior leadership will participate in a fireside chat on Tuesday, March 11, 2025 at 1:40 p.m. ET.
- Live webcast and replay will be available on the News & Events page of Zura Bio's website for at least 30 days.
- Zura Bio is a clinical-stage immunology company developing dual-pathway antibodies for autoimmune diseases.

## SEC filing metadata
- accession: 0001104659-25-016345
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465925016345/0001104659-25-016345-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465925016345/tm257217d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-016345
- JSON: https://secwatch.observer/filing/0001104659-25-016345.json
- Plain text: https://secwatch.observer/filing/0001104659-25-016345.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.